Tvardi Therapeutics Inc.
TVRD | IL
Overview
Corporate Details
- ISIN(s):
- US1407553072
- LEI:
- 549300COVOY41P0GZ881
- Country:
- United States of America
- Address:
- 3 Sugar Creek Ctr Blvd, Ste 525, TX 77478 Sugar Land
- Website:
- https://tvarditherapeutics.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Tvardi Therapeutics is a clinical stage, biotechnology company developing a new class of breakthrough medicines for fibrosis-driven diseases. Founded in 2017 and based in Houston, Texas, the company is led by experienced entrepreneurs, innovative scientists, and dedicated physicians.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
No filings match the current criteria. |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
|
Ascelia Pharma | Sweden | ACE | |
![]() |
Atrys Health S.A. | Spain | ATRY | |
![]() |
AUKETT SWANKE GROUP PLC | United Kingdom | AUK | |
|
Azorean - Aquatic Technologies S.A. | Portugal | MLAAT | |
|
Bachem Holding AG | Switzerland | BANB | |
![]() |
Bavarian Nordic | Denmark | BAVA | |
|
BB Biotech AG | Switzerland | BION | |
![]() |
BEEKS FINANCIAL CLOUD GROUP PLC | United Kingdom | BKS | |
![]() |
BenevolentAI | United Kingdom | BAI | |
![]() |
BerGenBio | Norway | BGBIO |